Research article · 2013
Review articlePublished 2015
Count Data Analysis in Randomised Clinical Trials
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Choosing the best model for analysis of count data in randomised clinical trials is complicated. In this paper, we review count data analysis with different parametric and non-parametric methods used in randomised clinical trials, and we define procedures for choosing between the two methods and their subtypes. We focus on analysis of simple count data and do not consider methods for analyzing longitudinal count data or Bayesian statistical analysis. We recommend that: (1) a detailed statistical analysis plan is published prior to access to trial data; (2) if there is lack of evidence for a parametric model, both non-parametric tests (either the van Elteren test or the Tadap2 test, based on an aligned rank test with equal stratum weights) and bootstrapping should be used as default methods; and (3) if more than two intervention groups are compared, then the Kruskal–Wallis test may be considered. If our recommendations are followed, the risk of biased results ensuing from analysis of count data in randomised clinical trials is expected to decrease.
Subjects
Mathematics & StatisticsAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 26 Jan 2016
An Analysis of Selection Models for Incomplete Longitudinal Clinical Trials Due to Dropout: An Application to Multi-centre Trial Data
Opinion · 2016
Design and Analysis of Clinical Trials, and Analysis of Correlated Data
Case report · 31 May 2023
Response to Insulin Glargine 100 U/Ml Treatment in Newly Identified Type 2 Diabetes Subgroups: Post Hoc Pooled Analysis of Patients in Nine Randomised Clinical Trials Who Have Never Taken Insulin
Mini review · 28 Nov 2022
A Meta-Analysis of a Randomised Clinical Trial on the use of Probiotics to Enhance the Therapy of Type II Diabetes Risk Factors in Individuals with Polycystic Ovarian Syndrome
More from this journal
The newest in Journal of Biometrics & Biostatistics.
Article · 29 Dec 2025
Biometrics Enhance EHR Security and Patient Safety
Article · 29 Dec 2025
Biometric and Clinical Data for Enhanced Risk Prediction
Article · 29 Dec 2025
Advanced Statistics for Precision Public Health Innovations
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biometrics & Biostatistics
- SubjectMathematics & Statistics
- BylineArticles whose byline prints “Jakobsen JC”
- BylineArticles whose byline prints “Tamborrino M”
- BylineArticles whose byline prints “Winkel P”
- BylineArticles whose byline prints “Haase N”
- BylineArticles whose byline prints “Perner A”
- BylineArticles whose byline prints “Wetterslev J”
- BylineArticles whose byline prints “Gluud C”

